We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.
BLPH

Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

37 hedge funds and large institutions have $18.2M invested in Bellerophon Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

10% less funds holding

Funds holding: 41 → 37 (-4)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

53% less capital invested

Capital invested by funds: $38.9M → $18.2M (-$20.6M)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
37
Holders Change
-4
Holders Change %
-9.76%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
12
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$754K
2
GCP
GSA Capital Partners
United Kingdom
+$258K
3
BlackRock
BlackRock
New York
+$231K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$187K
5
State Street
State Street
Massachusetts
+$168K

Top Sellers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
-$347K
2
Renaissance Technologies
Renaissance Technologies
New York
-$278K
3
TI
Telemetry Investments
New York
-$215K
4
TAM
Tocqueville Asset Management
New York
-$142K
5
WG
Winton Group
United Kingdom
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
26
US Bancorp
Minnesota
$8K – – –
Osaic Holdings
27
Osaic Holdings
Arizona
$7K – – –
SO
28
STRS Ohio
Ohio
$6K – – –
PFA
29
Professional Financial Advisors
Nebraska
$5K – – –
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$5K +$4.22K +515 +246%
Citigroup
31
Citigroup
New York
$5K +$4.67K +571 +266%
Legal & General Group
32
Legal & General Group
United Kingdom
$4K – – –
AIP
33
Ameritas Investment Partners
Nebraska
$2K – – –
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$2K – – –
PAM
35
Panagora Asset Management
Massachusetts
$1K – – –
FDCDDQ
36
Federation des caisses Desjardins du Quebec
Quebec, Canada
$447 – – –
AIG
37
American International Group
New York
$17 -$606 -74 -3%
AQR Capital Management
38
AQR Capital Management
Connecticut
– -$347K -34,071 Closed
WG
39
Winton Group
United Kingdom
– -$127K -12,498 Closed
RFWA
40
RPg Family Wealth Advisory
Massachusetts
– -$30.5K -3,000 Closed
EI
41
Ellevest Inc
New York
– -$1K -145 Closed
1
2

BLPH Hedge Fund Activity: Q4 2020 in Review

37 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q4 2020, worth a combined $18.2M — down 53% from $38.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BLPH and 1 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 12 added.

The largest buyer was Wells Fargo, adding an estimated $754K. The largest seller was AQR Capital Management, exiting entirely with an estimated $347K sold.

  • 37 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q4 2020, down from 41 in Q3 2020.
  • Funds reported $18.2M of Bellerophon Therapeutics, Inc. stock for Q4 2020, down 53% quarter-over-quarter.
  • 1 fund opened new Bellerophon Therapeutics, Inc. positions in Q4 2020 and 4 closed out, a net change of -3 holders.
  • The largest Bellerophon Therapeutics, Inc. buyer in Q4 2020 was Wells Fargo, an estimated $754K added.
  • The largest Bellerophon Therapeutics, Inc. seller in Q4 2020 was AQR Capital Management, an estimated $347K sold.

Based on aggregated 13F filings for Q4 2020.